Muscle Relaxant Pulled After Diabetes Drug Found

Dr. Reddy's Laboratories issued a voluntary recall for 150-count bottles of tizanidine hydrochloride tablets, USP, 2 mg (NDC 55111-179-15), after a glimepiride tablet was found in a bottle. The recall was included in the September 26, 2018, US Food and Drug Administration (FDA) Enforcement Report.

The recall affects 8376 units from lot T800304 (Exp. 3/21). The bottles were distributed within the United States.

Dr. Reddy's Laboratories initiated the recall September 4, 2018. On September 17, 2018, the FDA designated the recall Class II. Drugs affected by Class II recalls may cause temporary or medically reversible adverse health consequences if used. While remote, a possibility of serious harm also exists.

Tizanidine is a prescription drug used to treat muscle spasms caused by conditions such as multiple sclerosis and spinal cord injury. Glimepiride is a prescription medication used to control blood sugar in people with diabetes.

—Jolynn Tumolo

For more Pharmacy Learning Network articles, visit the homepage

To learn about Pharmacy Learning Network Live meetings, click here